Beta-Lactam Range
WHO-GMP certified penicillin-class formulations for infection-care portfolios.
- Amoxycillin & Clavulanate combinations
- Ampicillin capsules & suspensions
- Sultamicillin & Sulbactam formulations
- Tablets, capsules & dry syrups
WHO-GMP · GMP · GLP · ISO 9001:2015
Third-party manufacturer for beta-lactam, cephalosporins and general formulations
Contract manufacturing and private-label supply from dedicated beta-lactam and cephalosporin blocks at SIDCUL Haridwar — backed by ₹125 crore investment across two manufacturing units.
₹125 CrPlant Investment
3600MTablets / Annum
2000MCapsules / Annum
2 UnitsHaridwar & Kathua
Our Divisions
Three dedicated manufacturing ranges
Separate blocks and validated processes for beta-lactam antibiotics, cephalosporins and general formulations — domestic and export.
Cephalosporin Range
GMP & GLP certified cephalosporin oral solids and suspensions.
- Cefixime, Cefuroxime, Cefpodoxime
- Cephalexin, Cefadroxil, Cefaclor
- Combination anti-infective tablets
- Domestic & export dossiers
General Formulations
Broad therapeutic coverage in non-beta-lactam dedicated lines.
- Analgesics & anti-inflammatory
- Anticold, antihistamine & GI care
- Antibiotics, antimalarials & nutraceuticals
- 500+ SKUs in domestic catalog
About Sucantis
Forward integration of the Tiwari Group into pharmaceutical manufacturing
Sucantis Biotech Private Limited is the flagship manufacturing arm of Tiwari Group — producing quality formulations for domestic brands and export partners from Uttarakhand and J&K.
Unit-1 at SIDCUL Bahadrabad commenced licensed production in November 2023; Unit-2 at Kathua, J&K received its license in May 2025. Commercial production is underway and scaling across all three ranges.
- Dedicated beta-lactam & cephalosporin blocks
- Tablets, capsules & dry syrup capability
- Third-party, loan-licence & export manufacturing
Capacity
Annual manufacturing capacity (single shift)
Scalable oral solid and liquid oral capacity across segregated production blocks.
| Dosage Form | Beta-Lactam | Cephalosporin | General |
|---|---|---|---|
| Tablets | 1500 million | 1500 million | 600 million |
| Capsules | 300 million | 200 million | — |
| Dry Syrups | 20 million | 20 million | 5 million |
Why Sucantis
End-to-end third-party manufacturing partner
Built for CDMO relationships — from formulation supply to documentation-ready batch release.
Regulatory Excellence
WHO-GMP, GMP (Schedule M), GLP and ISO 9001:2015 certified operations with export neutral code.
Segregated Blocks
Dedicated beta-lactam, cephalosporin and general formulation areas with controlled cross-contamination prevention.
Experienced Leadership
Board and QA/QC heads with decades of experience at Akums, Zydus, Lupin, Glenmark and WHO inspections.
Domestic & Export
Product lists and dossier support for Indian retail networks and regulated export markets.
Compliance
Certified for quality you can audit
WHO
GMP
GMP
WHO-GMP Certified
WHO TRS guidelines for pharmaceutical manufacturing
GMP
Sch M
Sch M
Schedule M GMP
Revised Schedule M — Drugs & Cosmetics Rules
GLP
GLP Certified
Schedule L-1 laboratory practices
ISO
9001
9001
ISO 9001:2015
Quality management systems
Manufacturing Units
Two strategic locations
Unit-1 — Haridwar
SIDCUL, Bahadrabad · License Nov 2023Beta-lactam, cephalosporin and general formulation blocks with WHO-GMP certified tablet, capsule and dry syrup lines.
Unit DetailsUnit-2 — Kathua, J&K
License May 2025Expanded capacity for beta-lactam and cephalosporin manufacturing to serve growing domestic and export demand.
Unit DetailsReady to manufacture with Sucantis?
Share your product brief for beta-lactam, cephalosporin or general formulations — domestic or export.
Contact Us